Literature DB >> 1438304

Expression cloning of a reserpine-sensitive vesicular monoamine transporter.

J D Erickson1, L E Eiden, B J Hoffman.   

Abstract

A cDNA for a rat vesicular monoamine transporter, designated MAT, was isolated by expression cloning in a mammalian cell line (CV-1). The cDNA sequence predicts a protein of 515 amino acids with 12 putative membrane-spanning domains. The characteristics of [3H]serotonin accumulation by CV-1 cells expressing the cDNA clone suggested sequestration by an intracellular compartment. In cells permeabilized with digitonin, uptake was ATP dependent with an apparent Km of 1.3 microM. Uptake was abolished by the proton-translocating ionophore carbonylcyanide p-trifluoromethoxyphenylhydrazone and with tri-(n-butyl)tin, an inhibitor of the vacuolar H(+)-ATPase. The rank order of potency to inhibit uptake was reserpine > tetrabenazine > serotonin > dopamine > norepinephrine > epinephrine. Direct comparison of [3H]monoamine uptake indicated that serotonin was the preferred substrate. Photolabeling of membranes prepared from CV-1 cells expressing MAT with 7-azido-8-[125I]iodoketanserin revealed a predominant tetrabenazine-sensitive photolabeled glycoprotein with an apparent molecular mass of approximately 75 kDa. The mRNA that encodes MAT was present specifically in monoamine-containing cells of the locus coeruleus, substantia nigra, and raphe nucleus of rat brain, each of which expresses a unique plasma membrane reuptake transporter. The MAT cDNA clone defines a vesicular monoamine transporter representing a distinct class of neurotransmitter transport molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438304      PMCID: PMC50469          DOI: 10.1073/pnas.89.22.10993

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles.

Authors:  J P Henry; D Scherman
Journal:  Biochem Pharmacol       Date:  1989-08-01       Impact factor: 5.858

2.  Cloning and expression of a cocaine-sensitive rat dopamine transporter.

Authors:  J E Kilty; D Lorang; S G Amara
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

3.  Identification and purification of a functional amine transporter from bovine chromaffin granules.

Authors:  Y Stern-Bach; N Greenberg-Ofrath; I Flechner; S Schuldiner
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

4.  Photoaffinity labeling of the monoamine transporter of bovine chromaffin granules and other monoamine storage vesicles using 7-azido-8-[125I]iodoketanserin.

Authors:  M F Isambert; B Gasnier; P M Laduron; J P Henry
Journal:  Biochemistry       Date:  1989-03-07       Impact factor: 3.162

Review 5.  Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane.

Authors:  J P Henry; B Gasnier; M P Roisin; M F Isambert; D Scherman
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 6.  Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport.

Authors:  R G Johnson
Journal:  Physiol Rev       Date:  1988-01       Impact factor: 37.312

Review 7.  Bioenergetics of secretory vesicles.

Authors:  D Njus; P M Kelley; G J Harnadek
Journal:  Biochim Biophys Acta       Date:  1986

Review 8.  Mechanism of transport and storage of neurotransmitters.

Authors:  B I Kanner; S Schuldiner
Journal:  CRC Crit Rev Biochem       Date:  1987

9.  Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter.

Authors:  T Pacholczyk; R D Blakely; S G Amara
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

10.  Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

Authors:  S Shimada; S Kitayama; C L Lin; A Patel; E Nanthakumar; P Gregor; M Kuhar; G Uhl
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

View more
  108 in total

1.  Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Authors:  C G Blackmore; A Varro; R Dimaline; L Bishop; D V Gallacher; G J Dockray
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

2.  Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors:  W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

3.  A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.

Authors:  Catherine L Gallagher; Bradley T Christian; James E Holden; Onofre T Dejesus; Robert J Nickles; Laura Buyan-Dent; Barbara B Bendlin; Sandra J Harding; Charles K Stone; Barb Mueller; Sterling C Johnson
Journal:  Mov Disord       Date:  2011-06-02       Impact factor: 10.338

Review 4.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

5.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  Choline acetyltransferase: regulation and coupling with protein kinase and vesicular acetylcholine transporter on synaptic vesicles.

Authors:  Di Sha; Hong Jin; Richard D Kopke; Jang-Yen Wu
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 7.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

8.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

9.  An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Authors:  Angelica Ortiz; Jun Gui; Farima Zahedi; Pengfei Yu; Christina Cho; Sabyasachi Bhattacharya; Christopher J Carbone; Qiujing Yu; Kanstantsin V Katlinski; Yuliya V Katlinskaya; Simran Handa; Victor Haas; Susan W Volk; Angela K Brice; Kim Wals; Nicholas J Matheson; Robin Antrobus; Sonja Ludwig; Theresa L Whiteside; Cindy Sander; Ahmad A Tarhini; John M Kirkwood; Paul J Lehner; Wei Guo; Hallgeir Rui; Andy J Minn; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2019-01-14       Impact factor: 31.743

Review 10.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.